Taking up the cudgels for the traditional reactive oxygen and nitrogen species detection assays and their use in the cardiovascular system

[1]  V. Muzykantov,et al.  Targeting vascular (endothelial) dysfunction , 2017, British journal of pharmacology.

[2]  T. Münzel,et al.  Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function , 2017, British journal of pharmacology.

[3]  B. Kalyanaraman,et al.  Recent developments in detection of superoxide radical anion and hydrogen peroxide: Opportunities, challenges, and implications in redox signaling. , 2017, Archives of biochemistry and biophysics.

[4]  M. Trujillo,et al.  Sensitive detection and estimation of cell-derived peroxynitrite fluxes using fluorescein-boronate. , 2016, Free radical biology & medicine.

[5]  N. Ayas,et al.  Uncoupling of Vascular Nitric Oxide Synthase Caused by Intermittent Hypoxia , 2016, Oxidative medicine and cellular longevity.

[6]  T. Münzel,et al.  NOX2 amplifies acetaldehyde-mediated cardiomyocyte mitochondrial dysfunction in alcoholic cardiomyopathy , 2016, Scientific Reports.

[7]  C. Vettel,et al.  Redox Imaging Using Cardiac Myocyte-Specific Transgenic Biosensor Mice. , 2016, Circulation research.

[8]  Haitao Shen,et al.  Acute blood glucose fluctuation enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cytokine expression in vivo , 2016, Cardiovascular Diabetology.

[9]  T. Münzel,et al.  Nitroglycerin induces DNA damage and vascular cell death in the setting of nitrate tolerance , 2016, Basic Research in Cardiology.

[10]  M. Martí,et al.  Mechanism of the Reaction of Human Manganese Superoxide Dismutase with Peroxynitrite: Nitration of Critical Tyrosine 34. , 2016, Biochemistry.

[11]  Marco De Spirito,et al.  Imaging Reactive Oxygen Species-Induced Modifications in Living Systems , 2016, Antioxidants & redox signaling.

[12]  B. Kalyanaraman,et al.  A Critical Review of Methodologies to Detect Reactive Oxygen and Nitrogen Species Stimulated by NADPH Oxidase Enzymes: Implications in Pesticide Toxicity , 2016, Current Pharmacology Reports.

[13]  V. Belousov,et al.  HyPer Family Probes: State of the Art. , 2016, Antioxidants & redox signaling.

[14]  R. Mason,et al.  Imaging free radicals in organelles, cells, tissue, and in vivo with immuno-spin trapping , 2016, Redox biology.

[15]  T. Münzel,et al.  Influence of exercise training on proangiogenic TIE-2 monocytes and circulating angiogenic cells in patients with peripheral arterial disease , 2016, Clinical Research in Cardiology.

[16]  R. Schnabel,et al.  Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans. , 2015, European heart journal.

[17]  K. Lackner,et al.  Formation of 2-nitrophenol from salicylaldehyde as a suitable test for low peroxynitrite fluxes , 2015, Redox biology.

[18]  R. Touyz,et al.  Chemiluminescence and the Nox1-Nox2-Nox4 Triple Knockout. , 2015, Antioxidants & redox signaling.

[19]  FlemingIngrid,et al.  Response to Pagano et al. , 2015 .

[20]  Harald H. H. W. Schmidt,et al.  Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications , 2015, Antioxidants & redox signaling.

[21]  A. Cuadrado,et al.  Antioxidants in Translational Medicine , 2015, Antioxidants & redox signaling.

[22]  P. Galuppo,et al.  Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure , 2015, Hypertension.

[23]  T. Münzel,et al.  Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress , 2015, Antioxidants & redox signaling.

[24]  J. Stasch,et al.  Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats , 2015, BMC Pharmacology and Toxicology.

[25]  M. Jakubowska,et al.  Toward selective detection of reactive oxygen and nitrogen species with the use of fluorogenic probes — Limitations, progress, and perspectives , 2015, Pharmacological reports : PR.

[26]  FlemingIngrid,et al.  Unchanged NADPH Oxidase Activity in Nox1-Nox2-Nox4 Triple Knockout Mice: What Do NADPH-Stimulated Chemiluminescence Assays Really Detect? , 2015 .

[27]  T. Münzel,et al.  Change of walking distance in intermittent claudication: impact on inflammation, oxidative stress and mononuclear cells: a pilot study , 2015, Clinical Research in Cardiology.

[28]  J. Zweier,et al.  Endothelial nitric oxide synthase uncoupling: A novel pathway in OSA induced vascular endothelial dysfunction , 2015, Respiratory Physiology & Neurobiology.

[29]  T. Münzel,et al.  Gliptin and GLP‐1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide‐induced endotoxemia , 2015, Basic Research in Cardiology.

[30]  I. Bechmann,et al.  Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[31]  T. Münzel,et al.  The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity , 2014, PloS one.

[32]  Iain G. Johnston,et al.  The ‘mitoflash’ probe cpYFP does not respond to superoxide , 2014, Nature.

[33]  Grigori Enikolopov,et al.  Red fluorescent genetically encoded indicator for intracellular hydrogen peroxide , 2014, Nature Communications.

[34]  B. Kalyanaraman,et al.  Mitochondria-targeted spin traps: synthesis, superoxide spin trapping, and mitochondrial uptake. , 2014, Chemical research in toxicology.

[35]  T. Münzel,et al.  Effects of empagliflozin on oxidative stress and endothelial dysfunction in STZ-induced Type 1 diabetic rat , 2014 .

[36]  A. Waisman,et al.  eNOS uncoupling in cardiovascular diseases--the role of oxidative stress and inflammation. , 2014, Current pharmaceutical design.

[37]  M. N. Álvarez,et al.  Peroxynitrite, a potent macrophage‐derived oxidizing cytotoxin to combat invading pathogens , 2014, BioFactors.

[38]  E. Lubos,et al.  Glutathione Peroxidase-1 Deficiency Potentiates Dysregulatory Modifications of Endothelial Nitric Oxide Synthase and Vascular Dysfunction in Aging , 2014, Hypertension.

[39]  T. Münzel,et al.  Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models. , 2014, Antioxidants & redox signaling.

[40]  D. Harrison,et al.  Methods for detection of mitochondrial and cellular reactive oxygen species. , 2014, Antioxidants & redox signaling.

[41]  T. Münzel,et al.  Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. , 2014, Antioxidants & redox signaling.

[42]  T. Grosser,et al.  Nanocarriers for vascular delivery of anti-inflammatory agents. , 2014, Annual review of pharmacology and toxicology.

[43]  C. Sena,et al.  Endothelial dysfunction - a major mediator of diabetic vascular disease. , 2013, Biochimica et biophysica acta.

[44]  J. Lambeth,et al.  On the use of L-012, a luminol-based chemiluminescent probe, for detecting superoxide and identifying inhibitors of NADPH oxidase: a reevaluation. , 2013, Free radical biology & medicine.

[45]  T. Münzel,et al.  Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression. , 2013, European heart journal.

[46]  R. Korbut,et al.  Mechanisms of oxidative stress in human aortic aneurysms — Association with clinical risk factors for atherosclerosis and disease severity , 2013, International journal of cardiology.

[47]  Michael Hausding,et al.  CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction , 2013, Basic Research in Cardiology.

[48]  T. Münzel,et al.  Critical limb ischaemia is characterised by an increased production of whole blood reactive oxygen species and expression of TREM-1 on neutrophils. , 2013, Atherosclerosis.

[49]  Rafael Radi,et al.  Peroxynitrite, a Stealthy Biological Oxidant* , 2013, The Journal of Biological Chemistry.

[50]  C. Foster,et al.  Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats , 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

[51]  A. Rodriguez-Mateos,et al.  A multilevel analytical approach for detection and visualization of intracellular NO production and nitrosation events using diaminofluoresceins. , 2012, Free radical biology & medicine.

[52]  T. Münzel,et al.  Phenotypic characterisation of pro-inflammatory monocytes and dendritic cells in peripheral arterial disease , 2012, Thrombosis and Haemostasis.

[53]  T. Münzel,et al.  Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition. , 2012, Cardiovascular research.

[54]  Thomas F. Rau,et al.  Increased NADPH oxidase-derived superoxide is involved in the neuronal cell death induced by hypoxia-ischemia in neonatal hippocampal slice cultures. , 2012, Free radical biology & medicine.

[55]  R. Stocker,et al.  Actions of "antioxidants" in the protection against atherosclerosis. , 2012, Free radical biology & medicine.

[56]  H. Stenmark,et al.  p62 at the interface of autophagy, oxidative stress signaling, and cancer. , 2012, Antioxidants & redox signaling.

[57]  C. Rembold,et al.  Free radical biology of the cardiovascular system. , 2012, Clinical science.

[58]  F. Degertekin,et al.  Ultrasound Imaging of Oxidative Stress In Vivo with Chemically-Generated Gas Microbubbles , 2012, Annals of Biomedical Engineering.

[59]  T. Münzel,et al.  Hyperglycemia and oxidative stress in cultured endothelial cells--a comparison of primary endothelial cells with an immortalized endothelial cell line. , 2012, Journal of diabetes and its complications.

[60]  J. Lancaster.  Faculty Opinions recommendation of Global profiling of reactive oxygen and nitrogen species in biological systems: high-throughput real-time analyses. , 2012 .

[61]  T. Renné,et al.  Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress , 2011, Basic Research in Cardiology.

[62]  T. Münzel,et al.  Nitroglycerin-Induced Endothelial Dysfunction and Tolerance Involve Adverse Phosphorylation and S-Glutathionylation of Endothelial Nitric Oxide Synthase: Beneficial Effects of Therapy With the AT1 Receptor Blocker Telmisartan , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[63]  A. Waisman,et al.  Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction , 2011, Circulation.

[64]  T. Münzel,et al.  Vascular Dysfunction in Experimental Diabetes Is Improved by Pentaerithrityl Tetranitrate but Not Isosorbide-5-Mononitrate Therapy , 2011, Diabetes.

[65]  T. Münzel,et al.  Oxidative stress and endothelial dysfunction: Therapeutic implications , 2011, Annals of medicine.

[66]  A. Cuadrado,et al.  Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. , 2010, Current drug targets.

[67]  T. Münzel,et al.  Is oxidative stress a therapeutic target in cardiovascular disease? , 2010, European heart journal.

[68]  V. Víctor,et al.  Oxidative stress and endothelial dysfunction in cardiovascular disease: mitochondria-targeted therapeutics. , 2010, Current medicinal chemistry.

[69]  H. Schmidt,et al.  Comparative pharmacology of chemically distinct NADPH oxidase inhibitors , 2010, British journal of pharmacology.

[70]  U. Förstermann,et al.  Resveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice , 2010, Journal of Pharmacology and Experimental Therapeutics.

[71]  D. Harrison,et al.  Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. , 2010, American journal of physiology. Heart and circulatory physiology.

[72]  U. Förstermann,et al.  Pentaerythritol Tetranitrate Improves Angiotensin II–Induced Vascular Dysfunction via Induction of Heme Oxygenase-1 , 2010, Hypertension.

[73]  J. Lehmann,et al.  A new class of organic nitrates: investigations on bioactivation, tolerance and cross‐tolerance phenomena , 2009, British journal of pharmacology.

[74]  A. Daiber,et al.  Chemical model systems for cellular nitros(yl)ation reactions. , 2009, Free radical biology & medicine.

[75]  Z. Ungvari,et al.  Resveratrol Improves Endothelial Function: Role of TNFα and Vascular Oxidative Stress , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[76]  T. Münzel,et al.  Monitoring White Blood Cell Mitochondrial Aldehyde Dehydrogenase Activity: Implications for Nitrate Therapy in Humans , 2009, Journal of Pharmacology and Experimental Therapeutics.

[77]  Lambeth,et al.  Mechanisms of Vascular Smooth Muscle NADPH Oxidase 1 (Nox1) Contribution to Injury-Induced Neointimal Formation , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[78]  K. Lackner,et al.  Nitrate tolerance as a model of vascular dysfunction: Roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress , 2009, Pharmacological reports : PR.

[79]  D. Harrison,et al.  Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. , 2008, Journal of the American College of Cardiology.

[80]  D. Harrison,et al.  Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. , 2008, Free radical biology & medicine.

[81]  T. Kawamoto,et al.  Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. , 2008, Cardiovascular research.

[82]  U. Förstermann,et al.  Cyclooxygenase 2-Selective and Nonselective Nonsteroidal Anti-Inflammatory Drugs Induce Oxidative Stress by Up-Regulating Vascular NADPH Oxidases , 2008, Journal of Pharmacology and Experimental Therapeutics.

[83]  T. Münzel,et al.  AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats. , 2008, Free radical biology & medicine.

[84]  R. Brandes,et al.  First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. , 2008, Antioxidants & redox signaling.

[85]  U. Förstermann,et al.  Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. , 2008, Atherosclerosis.

[86]  I. Spasojević,et al.  Spin-trapping of oxygen free radicals in chemical and biological systems: new traps, radicals and possibilities. , 2008, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[87]  T. Kawamoto,et al.  ALDH-2 deficiency increases cardiovascular oxidative stress--evidence for indirect antioxidative properties. , 2008, Biochemical and biophysical research communications.

[88]  R. Schmieder,et al.  Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice. , 2008, American journal of physiology. Heart and circulatory physiology.

[89]  J. Lehmann,et al.  Heme Oxygenase-1: A Novel Key Player in the Development of Tolerance in Response to Organic Nitrates , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[90]  Andreas Daiber and Markus Bachschmid.  Enzyme Inhibition by Peroxynitrite-Mediated Tyrosine Nitration and Thiol Oxidation , 2007 .

[91]  D. Harrison,et al.  Measurement of reactive oxygen species in cardiovascular studies. , 2007, Hypertension.

[92]  Christian Gluud,et al.  Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. , 2007, JAMA.

[93]  M. Lim.  Preparation of a copper-based fluorescent probe for nitric oxide and its use in mammalian cultured cells , 2007, Nature Protocols.

[94]  R. Brandes,et al.  Nebivolol Inhibits Superoxide Formation by NADPH Oxidase and Endothelial Dysfunction in Angiotensin II–Treated Rats , 2006, Hypertension.

[95]  O. Pongs,et al.  NADPH Oxidase Accounts for Enhanced Superoxide Production and Impaired Endothelium-Dependent Smooth Muscle Relaxation in BK&bgr;1−/− Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[96]  S. Lippard,et al.  Visualization of nitric oxide in living cells by a copper-based fluorescent probe , 2006, Nature chemical biology.

[97]  K. Griendling,et al.  Lack of Long-Term Protective Effect of Antioxidant/Anti-Inflammatory Therapy in Transplant-Induced Ischemia/Reperfusion Injury , 2006, American Journal of Nephrology.

[98]  U. Förstermann,et al.  Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. , 2006, Journal of the American College of Cardiology.

[99]  신원용,et al.  露蜂房의 Peroxynitrite 제거 효과 , 2006 .

[100]  T. Münzel,et al.  Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. , 2005, Biochemical and biophysical research communications.

[101]  T. Münzel,et al.  Mechanisms of Increased Vascular Superoxide Production in an Experimental Model of Idiopathic Dilated Cardiomyopathy , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[102]  D. Harrison,et al.  Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[103]  T. Münzel,et al.  Heterozygous Deficiency of Manganese Superoxide Dismutase in Mice (Mn-SOD+/-): A Novel Approach to Assess the Role of Oxidative Stress for the Development of Nitrate Tolerance , 2005, Molecular Pharmacology.

[104]  R. Alexander,et al.  Role of gp91phox (Nox2)-Containing NAD(P)H Oxidase in Angiogenesis in Response to Hindlimb Ischemia , 2005, Circulation.

[105]  T. Münzel,et al.  Oxidative Stress and Mitochondrial Aldehyde Dehydrogenase Activity: A Comparison of Pentaerythritol Tetranitrate with Other Organic Nitrates , 2004, Molecular Pharmacology.

[106]  C. Gluud,et al.  Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis , 2004, The Lancet.

[107]  L. Berliner,et al.  Detection of bioradicals by in vivo L‐band electron spin resonance spectrometry , 2004, NMR in biomedicine.

[108]  A. Daiber,et al.  Detection of Superoxide and Peroxynitrite in Model Systems and Mitochondria by the Luminol Analogue L-012 , 2004, Free radical research.

[109]  J. Stamler,et al.  Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. , 2004, The Journal of clinical investigation.

[110]  G. FitzGerald,et al.  Oxidative stress and cardiovascular injury: Part II: animal and human studies. , 2003, Circulation.

[111]  G. FitzGerald,et al.  Oxidative Stress and Cardiovascular Injury: Part I: Basic Mechanisms and In Vivo Monitoring of ROS , 2003, Circulation.

[112]  K. Rockett,et al.  Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. , 2003, The Journal of clinical investigation.

[113]  U. Walter,et al.  Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[114]  D. Buerk,et al.  Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury , 2003, Nature Biotechnology.

[115]  H. Ischiropoulos,et al.  Oxidative stress and nitration in neurodegeneration: cause, effect, or association? , 2003, The Journal of clinical investigation.

[116]  M. Yorek.  The Role of Oxidative Stress in Diabetic Vascular and Neural Disease , 2003, Free radical research.

[117]  V. Ullrich,et al.  Stickstoffmonoxid, Superoxid und Peroxynitrit: Radikalchemie im Organismus , 2002 .

[118]  D. Harrison,et al.  Detection of Superoxide in Vascular Tissue , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[119]  U. Walter,et al.  Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits. , 2002, Journal of the American College of Cardiology.

[120]  Hua Cai,et al.  Role of p47phox in Vascular Oxidative Stress and Hypertension Caused by Angiotensin II , 2002, Hypertension.

[121]  D. Wink,et al.  Focusing of nitric oxide mediated nitrosation and oxidative nitrosylation as a consequence of reaction with superoxide , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[122]  Marie-Luise Brennan,et al.  A Tale of Two Controversies , 2002, The Journal of Biological Chemistry.

[123]  K. Channon,et al.  Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase , 2002, Circulation.

[124]  W. R. Taylor,et al.  Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis , 2002, Circulation.

[125]  R. Cohen,et al.  Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. , 2002, The Journal of clinical investigation.

[126]  U. Walter,et al.  Functional and Biochemical Analysis of Endothelial (Dys)function and NO/cGMP Signaling in Human Blood Vessels With and Without Nitroglycerin Pretreatment , 2002, Circulation.

[127]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[128]  D. Harrison,et al.  Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. , 2001, Free radical biology & medicine.

[129]  T. Münzel,et al.  Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus , 2001, Circulation research.

[130]  K. Channon,et al.  Enhanced Superoxide Production in Experimental Venous Bypass Graft Intimal Hyperplasia: Role of NAD(P)H Oxidase , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[131]  D. Harrison,et al.  Spin trapping of vascular nitric oxide using colloid Fe(II)-diethyldithiocarbamate. , 2000, Biochemical and biophysical research communications.

[132]  I. Fridovich,et al.  Lucigenin: Redox Potential in Aqueous Media and Redox Cycling with O−2 Production1☆ , 2000 .

[133]  K. Schoenafinger,et al.  Sensitive Superoxide Detection in Vascular Cells by the New Chemiluminescence Dye L-012 , 1999, Journal of Vascular Research.

[134]  E. Sato,et al.  Analysis of reactive oxygen species generated by neutrophils using a chemiluminescence probe L-012. , 1999, Analytical biochemistry.

[135]  M. Tarpey,et al.  Chemiluminescent detection of oxidants in vascular tissue. Lucigenin but not coelenterazine enhances superoxide formation. , 1999, Circulation research.

[136]  D. Harrison,et al.  Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. , 1999, Biochemical and biophysical research communications.

[137]  B. Davidson,et al.  Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. , 1998, Circulation research.

[138]  J. Zweier,et al.  Validation of Lucigenin (Bis-N-methylacridinium) as a Chemilumigenic Probe for Detecting Superoxide Anion Radical Production by Enzymatic and Cellular Systems* , 1998, The Journal of Biological Chemistry.

[139]  I. Fridovich,et al.  Lucigenin luminescence as a measure of intracellular superoxide dismutase activity in Escherichia coli. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[140]  H. Sies,et al.  Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.

[141]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[142]  S. Rajagopalan,et al.  Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. , 1996, The Journal of clinical investigation.

[143]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[144]  W. A. Bradley,et al.  Superoxide and peroxynitrite in atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[145]  P G Anderson,et al.  Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. , 1994, Biological chemistry Hoppe-Seyler.

[146]  Y. Nishinaka,et al.  A new sensitive chemiluminescence probe, L-012, for measuring the production of superoxide anion by cells. , 1993, Biochemical and biophysical research communications.

[147]  W. S. Caldwell,et al.  EPR evidence for nitric oxide production from guanidino nitrogens of L-arginine in animal tissues in vivo. , 1992, Biochimica et biophysica acta.

[148]  G. Bokoch,et al.  Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. , 1991, Science.

[149]  E. Pick,et al.  The membrane-associated component of the amphiphile-activated, cytosol-dependent superoxide-forming NADPH oxidase of macrophages is identical to cytochrome b559. , 1991, The Journal of biological chemistry.

[150]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[151]  E. Ferber,et al.  Lucigenin-dependent chemiluminescence as a new assay for NAD(P)H-oxidase activity in particulate fractions of human polymorphonuclear leukocytes. , 1984, Journal of immunological methods.

[152]  B. Babior,et al.  The particulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst. , 1976, The Journal of clinical investigation.

[153]  B. Babior,et al.  Defect in pyridine nucleotide dependent superoxide production by a particulate fraction from the cranulocytes of patients with chronic granulomatous disease. , 1975, The New England journal of medicine.

[154]  B. Babior,et al.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. , 1973, The Journal of clinical investigation.

[155]  J. Błasiak,et al.  Redox Biology , 2018 .

[156]  R. Brandes,et al.  Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH‐dependent lucigenin chemiluminescence in membrane assays , 2017, Free radical biology & medicine.

[157]  R. Brandes,et al.  Unchanged NADPH Oxidase Activity in Nox1-Nox2-Nox4 Triple Knockout Mice: What Do NADPH-Stimulated Chemiluminescence Assays Really Detect? , 2016, Antioxidants & redox signaling.

[158]  E. Pick.  Cell-free NADPH oxidase activation assays: "in vitro veritas". , 2014, Methods in molecular biology.

[159]  J. Joseph,et al.  Hydropropidine: a novel, cell-impermeant fluorogenic probe for detecting extracellular superoxide. , 2013, Free radical biology & medicine.

[160]  K. Davies,et al.  Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. , 2012, Free radical biology & medicine.

[161]  M. Watkins,et al.  S-glutathionylation uncouples eNOS and regulates its cellular and vascular function , 2011 .

[162]  B. Kalyanaraman,et al.  Detection of 2-hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine , 2007, Nature Protocols.

[163]  M. Yoshizumi,et al.  Nitrite-derived nitric oxide formation following ischemia-reperfusion injury in kidney. , 2005, American journal of physiology. Renal physiology.

[164]  A. Daiber,et al.  Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012. , 2004, Free radical biology & medicine.

[165]  D. Kereiakes,et al.  Endothelial dysfunction. , 2003, Circulation.

[166]  T. Münzel,et al.  Advanced spin trapping of vascular nitric oxide using colloid iron diethyldithiocarbamate. , 2002, Methods in enzymology.

[167]  I. Fridovich,et al.  Lucigenin: redox potential in aqueous media and redox cycling with O-(2) production. , 1999, Archives of biochemistry and biophysics.

[168]  D. Harrison,et al.  Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. , 1995, The Journal of clinical investigation.

[169]  W. Nauseef,et al.  Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. , 1991, The Journal of clinical investigation.

[170]  D. Harrison,et al.  Aha Scientific Statement on Behalf of the American Heart Association Council on Basic Cardiovascular Sciences. Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-dependent Signaling in the Cardiovascular System: a Scientific Statement from the American Heart Association. Me , 2022 .